# Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria

> **NCT01153893** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 105 (actual)

## Conditions studied

- Infections, Streptococcal

## Interventions

- **BIOLOGICAL:** Pneumococcal vaccine GSK1024850A
- **BIOLOGICAL:** InfanrixTM

## Key facts

- **NCT ID:** NCT01153893
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10-04
- **Primary completion:** 2011-02-16
- **Final completion:** 2011-02-16
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2018-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01153893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01153893, "Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01153893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*